1. Home
  2. ZYME vs VERX Comparison

ZYME vs VERX Comparison

Compare ZYME & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$27.00

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo Vertex Inc.

VERX

Vertex Inc.

HOLD

Current Price

$11.44

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZYME
VERX
Founded
2003
1978
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
ZYME
VERX
Price
$27.00
$11.44
Analyst Decision
Strong Buy
Buy
Analyst Count
11
14
Target Price
$38.90
$28.29
AVG Volume (30 Days)
522.6K
1.3M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
$105,965,000.00
$748,444,000.00
Revenue This Year
$180.13
$12.78
Revenue Next Year
N/A
$11.61
P/E Ratio
N/A
$302.25
Revenue Growth
38.87
12.25
52 Week Low
$10.69
$10.59
52 Week High
$28.49
$42.44

Technical Indicators

Market Signals
Indicator
ZYME
VERX
Relative Strength Index (RSI) 63.62 38.03
Support Level $22.28 N/A
Resistance Level $27.35 $20.04
Average True Range (ATR) 1.04 0.64
MACD 0.18 0.04
Stochastic Oscillator 91.56 41.54

Price Performance

Historical Comparison
ZYME
VERX

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About VERX Vertex Inc.

Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.

Share on Social Networks: